Pieris Pharmaceuticals Stock Quote PIRS - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

10.97

Bid

1.47

Ask

12.00

Volume

5,735

10.97 Day's Range 11.54

10.60 52 Week Range 80.80

Market Cap

1.084B

Previous Close

11.25

Open

11.21

Last Trade

10.36

Last Trade Time

Financial Volume

$ 64,177

VWAP

11.1904

Average Volume (3m)

605,075

Shares Outstanding

98,851,927

Dividend Yield

PE Ratio

-44.18

Earnings Per Share (EPS)

-0.25

Revenue

42.81M

Net Profit

-24.54M

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of mol... Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, PRS-343, and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm functions through the region of the United States. Show more

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.pieris.com

Headquarters

Las Vegas, Nevada, USA

Founded

1970

Pieris Pharmaceuticals Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker PIRS. The last closing price for Pieris Pharmaceuticals was $11.25. Over the last year, Pieris Pharmaceuticals shares have traded in a share price range of $ 10.60 to $ 80.80.

Pieris Pharmaceuticals currently has 98,851,927 shares outstanding. The market capitalization of Pieris Pharmaceuticals is $1.08 billion. Pieris Pharmaceuticals has a price to earnings ratio (PE ratio) of -44.18.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.03	-0.272727272727	11	11.54	10.87	5880	11.25672347	CS
4	-1.35	-10.9577922078	12.32	12.93	10.6	213804	11.63684361	CS
12	-1.934	-14.987600744	12.904	22.32	10.6	605075	14.83454061	CS
26	-7.43	-40.3804347826	18.4	22.32	10.6	548732	14.41861504	CS
52	-52.63	-82.751572327	63.6	80.8	10.6	1340884	21.62751866	CS
156	-141.83	-92.8206806283	152.8	492	10.6	1698973	214.56516505	CS
260	-290.63	-96.3627320955	301.6	496	10.6	1216429	223.05049657	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DUOFangDD Network Group Ltd	$ 1.65 (313.74%)	104.68M
FLJFLJ Group Limited	$ 1.54 (220.90%)	57.28M
JFBRJeffs Brands Ltd	$ 0.6276 (102.45%)	37.97M
IPWiPower Inc	$ 2.89 (97.95%)	11.05M
CETXCemtrex Inc	$ 0.4851 (48.58%)	21.23M
BSFCBlue Star Foods Corporation	$ 0.0757 (-45.26%)	60.09M
SINTSiNtx Technologies Inc	$ 0.084602 (-39.57%)	156.35M
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
HSCSHeart Test Laboratories Inc	$ 7.00 (-38.11%)	348.9k
AMPGAmplitech Group Inc	$ 1.46 (-32.09%)	613.31k
CRKNCrown Electrokinetics Corporation	$ 0.171 (-28.75%)	1.74B
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
GWAVGreenwave Technology Solutions Inc	$ 0.1541 (4.05%)	1.16B
AKANAkanda Corporation	$ 0.1726 (30.26%)	566.51M
PEGYPineapple Energy Inc	$ 0.1053 (-28.85%)	219.25M